BNET Industries
Market Cap:$148.5B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
REG-Pfizer Inc Pfizer Declares an 18-Cent First-Quarter 2010 Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Market Report -- In Play PFE
-
Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher's Disease
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Conservationists salute two corporations
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
2009: The Year That Was For Pfizer
News & Analysis
Filter by
pfizer inc. and software - All News and Analysis
Lilly, Pfizer and AstraZeneca Jockeying for Position on Healthcare Reform
BNET
- 2009-04-17
Eli Lilly, Pfizer, Bayer, Roche and AstraZeneca all agree on healthcare reform in the U.S.: They want to see the system changed so long as it in no way hurts their companies. by Jim Edwards
Swiss Allege Price Fixing on Viagra and Cialis
BNET
- 2009-02-10
Swiss authorities have accused Pfizer and Eli Lilly of conspiring to fix prices for Viagra and Cialis. The news has created the best Bloomberg headline ever: "Pfizer, Lilly, Bayer Operated Erection-Drug Cartel, Swiss Say." A couple of days ago BNET noted that Pfizer and Lilly appear to...
Starved of News, Press Speculates on Deals for Abbott, Pfizer and Wyeth
BNET
- 2009-01-05
New Year is a slow news period, which is why the business press filled up with next-to-useless corporate strategy stories about Abbott Labs, Wyeth and Pfizer. The one thing these stories all have in common? They're long on speculation and short on substance. Let's take them one at a time....
Pfizer Trovan Case: Doctor Sues Over Link to Nigerian Attorney General Who Allegedly Wants Slice of Settlement
BNET
- 2008-12-30
A Texas doctor helping the Nigerian government in its claim against Pfizer in the Trovan drug testing case has sued an African investigative reporting website, SaharaReporters, for $25 million, according to Black Star News. SaharaReporters had written that the doctor was a cousin of Nigeria's attorney general and that the...
NFL Locks Pfizer Exec Out of Player Health Meeting
BNET
- 2008-12-15
Pfizer's director of health policy, Eleanor Perfetto, was locked out of a meeting about former NFL players with health problems even though she is married to an ex-player with dementia and is thus not able to represent himself. Perfetto was barred from the meeting for the 19th Century-style reason that...
Pfizer's Viagra Will Not Be Sold Over the Counter in Europe
BNET
- 2008-11-20
Pfizer continues to meet resistance to its attempt to transform Viagra from a legitimate drug for a real medical condition into a party drug that promises "a more satisfying sexual experience." Today Pfizer announced that it has withdrawn its application to sell Viagra as an OTC medicine in Europe. The...
Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit
- 2008-10-22
NEW YORK -- Pfizer announced today that it has named Mace L. Rothenberg, M.D. as Senior Vice President, Clinical Development and Medical Affairs for its Oncology Business Unit. Dr. Rothenberg comes to Pfizer from Vanderbilt where he was Professor of Medicine at the Vanderbilt University Medical Center and Ingram Professor...
EPA Honors Pfizer for Reducing Greenhouse Gas Emissions
- 2008-10-08
Company Exceeds Initial Goal; Pledges 20 Percent Reduction Between Now and 2012 NEW YORK -- The U.S. Environmental Protection Agency EPA honored Pfizer Inc today in recognition of the company's award-winning Energy and Climate Change Program, which reduced total greenhouse gas emissions by 43 percent per million dollars...
EPA Applauds Pfizer's Efforts to Reduce GHG Emissions
- 2008-10-08
ENERGY RESOURCE-8 October 2008-EPA Applauds Pfizer's Efforts to Reduce GHG EmissionsC2008 JeraOne - http://www.jeraone.com The U.S. Environmental Protection Agency EPA honored Pfizer Inc. today for its Energy and Climate Change Program, which reduced total greenhouse gas emissions by 43 percent per million dollars of revenue from 2000 to 2007....
Grameen Health to Establish Independent Collaborations with Pfizer, GE Healthcare, and Mayo Clinic to Create Sustainable Healthcare Delivery Models for the Developing World
- 2008-09-24
Partnerships Will Support Development of Business Models That Meet the Health Needs of 4 Billion People Around the World Who Live on Annual Incomes of Less Than $3,000 BOSTON -- Grameen Health, an affiliate of Grameen Bank, the pioneering micro-financing organization in Bangladesh that shared the Nobel Peace Prize...
Industry Transcripts by Seeking Alpha
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
Presented by American Express